Management of venous thrombosis in the pediatric patient

被引：8
作者：
Radulescu, Vlad C. [1 ]
机构：
[1] Univ Kentucky, Dept Pediat, KY Clinic J453,740 S Limestone St, Lexington, KY 40536 USA
来源：
PEDIATRIC HEALTH MEDICINE AND THERAPEUTICS | 2015年 / 6卷
关键词：
venous thromboembolism; children; anticoagulant therapy; thrombolytic therapy;
D O I：
10.2147/PHMT.S65697
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
The incidence of venous thromboembolism in children has increased significantly over the past decade. The evaluation and management of the child with venous thromboembolism, while based on the adult experience, has its own particularities dictated by the differences in the hemostatic system of the newborn and child. The current review addresses the evaluation of pediatric patient with thrombosis as well as the established and emerging treatment interventions.
引用
收藏
页码：111 / 119
页数：9
相关论文
共 63 条
[31]   Children Suspected of Having Pulmonary Embolism: Multidetector CT Pulmonary Angiography-Thromboembolic Risk Factors and Implications for Appropriate Use [J].
Lee, Edward Y. ;
Tse, Sunny K. S. ;
Zurakowski, David ;
Johnson, Victor M. ;
Lee, Nam Ju ;
Tracy, Donald A. ;
Boiselle, Phillip M. .
RADIOLOGY, 2012, 262 (01) :242-251
[32]   New developments in pediatric venous thromboembolism and anticoagulation, including the target-specific oral anticoagulants [J].
Lyle, Courtney A. ;
Sidonio, Robert F. ;
Goldenberg, Neil A. .
CURRENT OPINION IN PEDIATRICS, 2015, 27 (01) :18-25
[33]   Significant association with location of central venous line placement and risk of venous thrombosis in children [J].
Male, C ;
Julian, JA ;
Massicotte, P ;
Gent, M ;
Mitchell, L .
THROMBOSIS AND HAEMOSTASIS, 2005, 94 (03) :516-521
[34]   How I treat venous thrombosis in children [J].
Manco-Johnson, MJ .
BLOOD, 2006, 107 (01) :21-29
[35]  
Manco-Johnson MJ, 2002, THROMB HAEMOSTASIS, V88, P157
[36]   Central venous catheter related thrombosis in children: Analysis of the Canadian Registry of venous thromboembolic complications [J].
Massicotte, MP ;
Dix, D ;
Monagle, P ;
Adams, M ;
Andrew, M .
JOURNAL OF PEDIATRICS, 1998, 133 (06) :770-776
[37]   An open-label randomized controlled trial of low molecular weight heparin compared to heparin and coumadin for the treatment of venous thromboembolic events in children: the REVIVE trial [J].
Massicotte, P ;
Julian, JA ;
Gent, M ;
Shields, K ;
Marzinotto, V ;
Szechtman, B ;
Andrew, M .
THROMBOSIS RESEARCH, 2003, 109 (2-3) :85-92
[38]   An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trial [J].
Massicotte, P ;
Julian, JA ;
Gent, M ;
Shields, K ;
Marzinotto, V ;
Szechtman, B ;
Chan, AK ;
Andrew, M .
THROMBOSIS RESEARCH, 2003, 109 (2-3) :101-108
[39]   Comparison of low-molecular-weight heparin and antithrombin versus antithrombin alone for the prevention of symptomatic venous thromboembolism in children with acute lymphoblastic leukemia [J].
Meister, Bernhard ;
Kropshofer, Gabriele ;
Klein-Franke, Andreas ;
Strasak, Alexander M. ;
Hager, Josef ;
Streif, Werner .
PEDIATRIC BLOOD & CANCER, 2008, 50 (02) :298-303
[40]   Trend to efficacy and safety using antithrombin concentrate in prevention of thrombosis in children receiving l-asparaginase for acute lymphoblastic leukemia - Results of the PARKAA study [J].
Mitchell, L ;
Andrew, M ;
Hanna, K ;
Abshire, T ;
Halton, J ;
Wu, J ;
Anderson, R ;
Cherrick, I ;
Desai, S ;
Mahoney, D ;
McCusker, P ;
Chait, P ;
Abdolell, M ;
de Veber, G ;
Mikulis, D .
THROMBOSIS AND HAEMOSTASIS, 2003, 90 (02) :235-244
1234567